Clinical Trial: An Early Phase Study of RT-114

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06891287) titled 'An Early Phase Study of RT-114' on March 07.

Brief Summary: The goal of this Phase 1 study is to evaluate the safety and tolerability of RT-114 in healthy volunteers. The main objectives are:

Primary: To evaluate safety and tolerability of RT-114 when administered as single and multiple doses by assessing treatment emergent adverse events (TEAEs) in healthy volunteers

Secondary:

* To determine the pharmacokinetics of RT-114 administered as single and multiple doses

* To determine the pharmacodynamic effects of RT-114 administered as multiple doses

In the single dose portion of the study participants will either receive the dru...